Related Experiment Videos
Systemic lupus erythematosus: obstetric and neonatal implications
Naacog'S Clinical Issues in Perinatal and Women'S Health Nursing
|January 1, 1990
Summary
Systemic lupus erythematosus (SLE) significantly impacts pregnancy, increasing risks for mothers and fetuses. Careful monitoring is crucial for managing SLE during pregnancy and protecting the neonate.
Area of Science:
- Rheumatology
- Obstetrics
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease impacting collagen vascular tissues.
- Pregnancy in women with SLE presents unique challenges and risks.
Purpose of the Study:
- To describe the effects of SLE on maternal health during pregnancy.
- To outline the risks to fetal development and neonatal outcomes in SLE pregnancies.
- To highlight the importance of specialized obstetrical care for pregnant SLE patients.
Main Methods:
- Review of clinical manifestations and outcomes in pregnant SLE patients.
- Discussion of diagnostic criteria for SLE.
- Analysis of the role of autoantibodies in SLE pregnancies.
Main Results:
- Pregnant SLE patients face increased risks of fetal wastage, intrauterine growth retardation (IUGR), intrauterine fetal demise (IUFD), and pregnancy-induced hypertension (PIH).
- SLE can exacerbate during pregnancy.
- Neonates may exhibit complications like skin lesions and complete heart block.
Conclusions:
- SLE significantly complicates pregnancy, affecting maternal, fetal, and neonatal health.
- Early diagnosis and intensive multidisciplinary care are essential for managing SLE in pregnancy.
- Further research into autoantibodies and their role in fetal outcomes is warranted.